Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Sleep apnea could be costing you brain power and increasing your risk of dementia and Alzheimer's disease, a new study says.

Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...

Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Eli Lilly and Company's Zepbound demonstrated superior weight reduction compared to Novo Nordisk's Wegovy in a 72-week ...

The Food and Drug Administration (FDA) has also approved Zepbound to help with sleep apnea in people with obesity. A valid prescription from a licensed healthcare provider is needed to get Zepbound.

The Food and Drug Administration (FDA) has approved Zepbound to help treat obstructive sleep apnea (OSA) in people with obesity. The drug also has FDA approval as a weight loss and weight ...